Lv1
80 积分 2021-09-13 加入
Circulating DNA changes are predictive of disease progression after transarterial chemoembolization
1天前
待确认
Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis
1天前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2天前
已完结
Cell‐Free Virus‐Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer
2天前
已完结
Hallmarks of cancer—Then and now, and beyond
2天前
已完结
Risk-adaptive Therapy Guided by Dynamic ctDNA in Nasopharyngeal Carcinoma
6天前
已完结
Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials
9天前
已完结
Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring
21天前
已完结
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection
21天前
已完结
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib
1个月前
已完结
皖公网安备34019202002308
